Search - tctmd.com

Displaying 921 - 940 of 7390

Sort: Relevancy | Date

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Daily News

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

L.A. McKeown

October 24, 2022

News Features

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

L.A. McKeown

October 18, 2022

News Daily News

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

L.A. McKeown

October 13, 2022

News Conference News TCT 2022

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Yael L. Maxwell

September 27, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

L.A. McKeown

September 20, 2022

Presentation TCT 2022

Iliocaval Stenting and Reconstructions With Extreme Case Examples

Presenter: S. Jay Mathews

September 19, 2022

Presentation TCT 2022

Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

Presenter: Robert Lookstein

September 19, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Should We Be Stenting All Patients Presenting With STEMI? Pros and Cons

Presenter: Andrejs Erglis

September 19, 2022

Presentation TCT 2022

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

Presenter: Pablo Salinas

September 19, 2022

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

Presentation TCT 2022

TCT 165: A Novel Ticagrelor Coated Stent to Eliminate the Need for Anti Platelet Therapy Post PCI

Presenter: Jared Romeo

September 19, 2022

Presentation TCT 2022

Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial

Presenter: Antonio Mangieri

September 19, 2022

Presentation TCT 2022

EXpansion of Stents After Intravascular lithoTripsy vs Conventional Predilatation in CALCified Coronary Arteries

Presenter: Maarten Vink

September 19, 2022

Presentation TCT 2022

TCT 272: Optimal Minimal Stent Area For Left Main Crush Technique Based On Long-Term Clinical Outcome

Presenter: Jung-Min Ahn

September 19, 2022

Presentation TCT 2022

TCT 33: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Chronic Kidney Diabetes: Results From the PTRG-DES Registry

Presenter: Sang Yeub Lee

September 19, 2022

Advertisement

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Valve Fracture for ViV TAVI Linked With Higher Mortality

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

Iliocaval Stenting and Reconstructions With Extreme Case Examples

Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Should We Be Stenting All Patients Presenting With STEMI? Pros and Cons

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

TCT 165: A Novel Ticagrelor Coated Stent to Eliminate the Need for Anti Platelet Therapy Post PCI

Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial

EXpansion of Stents After Intravascular lithoTripsy vs Conventional Predilatation in CALCified Coronary Arteries

TCT 272: Optimal Minimal Stent Area For Left Main Crush Technique Based On Long-Term Clinical Outcome

TCT 33: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Chronic Kidney Diabetes: Results From the PTRG-DES Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content